Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Scott M. Teeter

Internal Medicine
901 Sw Garfield Ave, 
Topeka, KS 
Accepting New Patients

Experienced in WT1-Related Wilms Tumor Syndromes
901 Sw Garfield Ave, 
Topeka, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Scott Teeter is a primary care provider, practicing in Internal Medicine in Topeka, Kansas. Dr. Teeter is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Melorheostosis with Osteopoikilosis, Osteopenia, Melorheostosis, and Type 2 Diabetes (T2D). Dr. Teeter is currently accepting new patients.

His clinical research consists of participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in KS
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO

Locations

901 Sw Garfield Ave, Topeka, KS 66606
Call: 785-354-9591

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 3
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: October 10, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. James A. Barnett
Internal Medicine
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. James A. Barnett
Internal Medicine
901 Sw Garfield Ave, 
Topeka, KS 
 (0.1 miles away)
785-354-9591
Languages Spoken:
English
See accepted insurances

James Barnett is a primary care provider, practicing in Internal Medicine in Topeka, Kansas. Dr. Barnett is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Urinary Tract Infection in Children, Lung Cancer, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Richard E. Whitlow
Internal Medicine
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Richard E. Whitlow
Internal Medicine
1004 Progress Dr, Ste 220, 
Lansing, KS 
 (44.5 miles away)
913-772-8200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Whitlow is a primary care provider, practicing in Internal Medicine in Lansing, Kansas. Dr. Whitlow is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Hypothyroidism, Vascular Dementia, Osteoarthritis, and Enlarged Prostate (BPH). Dr. Whitlow is currently accepting new patients.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Micholee B. Polsak
Internal Medicine
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Micholee B. Polsak
Internal Medicine

Kansas University Physicians Inc

3901 Rainbow Blvd, 
Kansas City, KS 
 (58.4 miles away)
913-588-7013
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Micholee Polsak is a primary care provider, practicing in Internal Medicine in Kansas City, Kansas. Dr. Polsak is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Atrial Tachycardia, and Paroxysmal Supraventricular Tachycardia (PSVT). Dr. Polsak is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Teeter's expertise for a condition
ConditionClose
      • Advanced
      • Melorheostosis
        Dr. Teeter is
        Advanced
        . Learn about Melorheostosis.
        See more Melorheostosis experts
      • Melorheostosis with Osteopoikilosis
        Dr. Teeter is
        Advanced
        . Learn about Melorheostosis with Osteopoikilosis.
        See more Melorheostosis with Osteopoikilosis experts
      • Osteopenia
        Dr. Teeter is
        Advanced
        . Learn about Osteopenia.
        See more Osteopenia experts
      • Experienced
      • Adult Immune Thrombocytopenia
        Dr. Teeter is
        Experienced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Alzheimer's Disease
        Dr. Teeter is
        Experienced
        . Learn about Alzheimer's Disease.
        See more Alzheimer's Disease experts
      • Asthma
        Dr. Teeter is
        Experienced
        . Learn about Asthma.
        See more Asthma experts
      • Asthma in Children
        Dr. Teeter is
        Experienced
        . Learn about Asthma in Children.
        See more Asthma in Children experts
      • Atherosclerosis
        Dr. Teeter is
        Experienced
        . Learn about Atherosclerosis.
        See more Atherosclerosis experts
      • Cellulitis
        Dr. Teeter is
        Experienced
        . Learn about Cellulitis.
        See more Cellulitis experts
      View All 65 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved